Ted Greene
Gründer bei CoDa Therapeutics (NZ) Ltd.
Profil
Ted Greene was the founder of Vical, Inc. (1987), Amylin Pharmaceuticals, Inc. (1987), CoDa Therapeutics (NZ) Ltd.
(2003), and Biovest Partners (1986).
He held the title of Director at Vical, Inc. and Amylin Pharmaceuticals, Inc., and Partner at Biovest Partners.
Currently, Mr. Greene is the Chairman of Satiogen Pharmaceuticals, Inc. and a Director at CONNECT.
Mr. Greene's former positions include Chief Executive Officer at Hybritech, Inc. (1979-1986), Director at Alere San Diego, Inc. (1989-2007), Independent Director at Tandem Diabetes Care, Inc. (2008-2020), and Director at Biosite, Inc. (Massachusetts) (1989-2007), among others.
Mr. Greene's education includes an undergraduate degree from Amherst College and an MBA from Harvard Business School.
Aktive Positionen von Ted Greene
| Unternehmen | Position | Beginn |
|---|---|---|
CoDa Therapeutics (NZ) Ltd.
 CoDa Therapeutics (NZ) Ltd. Pharmaceuticals: MajorHealth Technology CoDa Therapeutics (NZ) Ltd. develops and markets biopharmaceutical products. The company was founded by David Becker, Colin Green, Bradford J, Duft, and Howard E. Greene and on December 9, 2003 and is headquartered in Auckland, New Zealand. | Gründer | 19.12.2003 |
Satiogen Pharmaceuticals, Inc.
 Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Satiogen Pharmaceuticals, Inc. engages in the development of therapeutic treatments for diabetes and obesity. It offers a metabolic mechanism for treating diabetes and obesity without intervention by systemically absorbed pharmaceuticals or invasive surgical methods. The firm’s product strategies include non-absorbed ASBT inhibitor, non-surgical biliary shunt, rectal satiogen, non-absorbed TGR5 ligand and labile bile acid sequestrant. The company was founded by Andrew Young and Bronislava Gedulin in 2007 and is headquartered in Del Mar, CA. | Vorsitzender | - |
CONNECT
 CONNECT Miscellaneous Commercial ServicesCommercial Services CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ted Greene
| Unternehmen | Position | Ende |
|---|---|---|
| TANDEM DIABETES CARE, INC. | Direktor/Vorstandsmitglied | 27.05.2020 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Vorstandsvorsitzender | 11.07.1996 |
Alere San Diego, Inc.
 Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 01.01.2007 |
| Biosite, Inc. (Massachusetts) | Direktor/Vorstandsmitglied | 01.01.2007 |
| Epimmune, Inc. | Vorsitzender | 17.08.2005 |
Ausbildung von Ted Greene
| Amherst College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TANDEM DIABETES CARE, INC. | Health Technology |
| Private Unternehmen | 17 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Neurex Corp.
 Neurex Corp. Pharmaceuticals: MajorHealth Technology Neurex Corporation is a developmental biopharmaceutical company focused on acute care therapeutics for the treatment of diverse neurological and cardiovascular indications. | Health Technology |
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | Health Technology |
Hybritech, Inc.
 Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Commercial Services |
| Epimmune, Inc. | Health Technology |
OcuNexus Therapeutics, Inc.
 OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA. | Health Technology |
Lumena Pharmaceuticals, Inc.
 Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lumena Pharmaceuticals, Inc. developed oral therapeutics for rare liver diseases. The firm was engaged in the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as nonalcoholic steatohepatitis. The company was founded by Bronislava Gedulin and Michael G. Grey in January 2011 and was headquartered in San Diego, CA. | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Pyxis Corp.
 Pyxis Corp. Tools & HardwareConsumer Durables Pyxis Corp. used to manufacture hardware distribution equipment and related healthcare logistics equipment. It also provided medication and supply dispensing systems to hospitals, nursing homes and other healthcare facilities. The company was founded in 1987 and was headquartered in San Diego, CA. | Consumer Durables |
IDM Pharma, Inc.
 IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | Health Technology |
CoDa Therapeutics (NZ) Ltd.
CoDa Therapeutics (NZ) Ltd. Pharmaceuticals: MajorHealth Technology CoDa Therapeutics (NZ) Ltd. develops and markets biopharmaceutical products. The company was founded by David Becker, Colin Green, Bradford J, Duft, and Howard E. Greene and on December 9, 2003 and is headquartered in Auckland, New Zealand. | Health Technology |
CONNECT
CONNECT Miscellaneous Commercial ServicesCommercial Services CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA. | Commercial Services |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Satiogen Pharmaceuticals, Inc. engages in the development of therapeutic treatments for diabetes and obesity. It offers a metabolic mechanism for treating diabetes and obesity without intervention by systemically absorbed pharmaceuticals or invasive surgical methods. The firm’s product strategies include non-absorbed ASBT inhibitor, non-surgical biliary shunt, rectal satiogen, non-absorbed TGR5 ligand and labile bile acid sequestrant. The company was founded by Andrew Young and Bronislava Gedulin in 2007 and is headquartered in Del Mar, CA. | Commercial Services |
| Biosite, Inc. (Massachusetts) | |
| Biovest Partners |
